A Majumdar, S Saraf, SP Rao - Pharmacological Research-Natural …, 2024 - Elsevier
Introduction Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for approximately 85% of all malignant kidney tumors. Despite advances in …
SP Verma, A Agarwal, P Das - In Vitro Cellular & Developmental Biology …, 2018 - Springer
Sodium butyrate (SB), a histone deacetylase inhibitor, is emerging as a potent anti-cancer drug for different types of cancers. In the present study, anti-cancer activity of SB in Xp11. 2 …
C Feng, Y Lyu, L Gong, J Wang - Nutrients, 2022 - mdpi.com
Renal cell carcinoma (RCC) is a common cancer of the urinary system. The potential therapeutic effects of certain natural products against renal cell carcinoma have been …